Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Nestrasil

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Orphanet Journal of Rare Diseases|July 7, 2018
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trialRoberto Giugliani, Luciana Giugliani, Fabiano de Oliveira Poswar, et al.
Frontiers in Neuroscience|January 10, 2018
Multi-modal Brain MRI in Subjects with PD and iRBDSilvia Mangia, Alena Svatkova, Daniele Mascali, et al.
Frontiers in Neuroscience|July 6, 2018
Corrigendum: Multi-modal Brain MRI in Subjects with PD and iRBDSilvia Mangia, Alena Svatkova, Daniele Mascali, et al.
Molecular Genetics and Metabolism|December 27, 2014
Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type IIBrianna Yund, Kyle Rudser, Alia Ahmed, et al.
Neurology|August 16, 2024
Diffusion Tensor Imaging in Boys With Adrenoleukodystrophy: Identification of Cerebral Disease and Association With Neurocognitive OutcomesElizabeth I Pierpont, René Labounek, Ashish Gupta, et al.
American Heart Journal Plus : Cardiology Research and Practice|November 24, 2025
<i>APOE ε4</i> and ischemic heart disease in American Indian/Indigenous tribal EldersRene Labounek, Matti J Matheson, Ashley J Petersen, et al.
Molecular Genetics and Metabolism|December 17, 2019
Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot studyAgnes H Chen, Paul Harmatz, Igor Nestrasil, et al.
Neurology|April 14, 2019
Attention and corpus callosum volumes in individuals with mucopolysaccharidosis type IKelly E King, Kyle D Rudser, Igor Nestrasil, et al.
Comparative Medicine|April 16, 2013
Features of brain MRI in dogs with treated and untreated mucopolysaccharidosis type ICharles H Vite, Igor Nestrasil, Anton Mlikotic, et al.
Experimental Neurology|July 30, 2015
Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis IJames M Provenzale, Igor Nestrasil, Steven Chen, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Orphanet Journal of Rare Diseases|July 7, 2018
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trialRoberto Giugliani, Luciana Giugliani, Fabiano de Oliveira Poswar, et al.
Frontiers in Neuroscience|January 10, 2018
Multi-modal Brain MRI in Subjects with PD and iRBDSilvia Mangia, Alena Svatkova, Daniele Mascali, et al.
Frontiers in Neuroscience|July 6, 2018
Corrigendum: Multi-modal Brain MRI in Subjects with PD and iRBDSilvia Mangia, Alena Svatkova, Daniele Mascali, et al.
Molecular Genetics and Metabolism|December 27, 2014
Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type IIBrianna Yund, Kyle Rudser, Alia Ahmed, et al.
Neurology|August 16, 2024
Diffusion Tensor Imaging in Boys With Adrenoleukodystrophy: Identification of Cerebral Disease and Association With Neurocognitive OutcomesElizabeth I Pierpont, René Labounek, Ashish Gupta, et al.
American Heart Journal Plus : Cardiology Research and Practice|November 24, 2025
<i>APOE ε4</i> and ischemic heart disease in American Indian/Indigenous tribal EldersRene Labounek, Matti J Matheson, Ashley J Petersen, et al.
Molecular Genetics and Metabolism|December 17, 2019
Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot studyAgnes H Chen, Paul Harmatz, Igor Nestrasil, et al.
Neurology|April 14, 2019
Attention and corpus callosum volumes in individuals with mucopolysaccharidosis type IKelly E King, Kyle D Rudser, Igor Nestrasil, et al.
Comparative Medicine|April 16, 2013
Features of brain MRI in dogs with treated and untreated mucopolysaccharidosis type ICharles H Vite, Igor Nestrasil, Anton Mlikotic, et al.
Experimental Neurology|July 30, 2015
Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis IJames M Provenzale, Igor Nestrasil, Steven Chen, et al.
Pageof 5